Gary S Goldman

Summary

Publications

  1. ncbi request reprint Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance
    Gary S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4238-42. 2003
  2. ncbi request reprint Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage
    G S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4243-9. 2003
  3. ncbi request reprint Using capture-recapture methods to assess varicella incidence in a community under active surveillance
    G S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4250-5. 2003
  4. ncbi request reprint Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology
    G S Goldman
    Medical Veritas International MVI, Pearblossom, CA 93553, USA
    Vaccine 23:3349-55. 2005
  5. ncbi request reprint Universal varicella vaccination: efficacy trends and effect on herpes zoster
    Gary S Goldman
    Medical Veritas International MVI, Pearblossom, California 93553, USA
    Int J Toxicol 24:205-13. 2005
  6. ncbi request reprint The case against universal varicella vaccination
    Gary S Goldman
    Medical Veritas International Inc, Pearblossom, California 93553, USA
    Int J Toxicol 25:313-7. 2006
  7. ncbi request reprint Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
    Jane F Seward
    Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop E 62, Atlanta, GA 30333, USA
    JAMA 287:606-11. 2002

Detail Information

Publications7

  1. ncbi request reprint Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance
    Gary S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4238-42. 2003
    ..Based on 4216 respondents aged 10-14 years, varicella susceptibility is 7.7% (95% CI, 6.9-8.5%) and true cumulative (1987-2000) HZ incidence rate is 133 per 100,000 person-years (95% CI, 95-182 per 100,000 person-years)...
  2. ncbi request reprint Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage
    G S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4243-9. 2003
    ..Unvaccinated children with a previous history of varicella may have greater sensitivity to exogenous exposures (boosting) and a poorer cell-mediated response following primary infection relative to older age groups...
  3. ncbi request reprint Using capture-recapture methods to assess varicella incidence in a community under active surveillance
    G S Goldman
    P O Box 847, Pearblossom, CA 93553, USA
    Vaccine 21:4250-5. 2003
    ..Despite limitations on accuracy, capture-recapture estimates are a reasonably accurate, quick, and inexpensive approach in epidemiologic studies...
  4. ncbi request reprint Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology
    G S Goldman
    Medical Veritas International MVI, Pearblossom, CA 93553, USA
    Vaccine 23:3349-55. 2005
    ..1 billion US dollars or 80 million US dollars annually utilizing an estimated mean healthcare provider cost of 280 US dollars per HZ case...
  5. ncbi request reprint Universal varicella vaccination: efficacy trends and effect on herpes zoster
    Gary S Goldman
    Medical Veritas International MVI, Pearblossom, California 93553, USA
    Int J Toxicol 24:205-13. 2005
    ..It may be difficult to design booster interventions that are cost-effective and meet or exceed the level of protection provided by immunologic boosting that existed naturally in the community in the prelicensure era...
  6. ncbi request reprint The case against universal varicella vaccination
    Gary S Goldman
    Medical Veritas International Inc, Pearblossom, California 93553, USA
    Int J Toxicol 25:313-7. 2006
    ..Deleterious outcomes and their associated costs must be included when making a circumspect assessment of the Universal Varicella Vaccination Program...
  7. ncbi request reprint Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
    Jane F Seward
    Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop E 62, Atlanta, GA 30333, USA
    JAMA 287:606-11. 2002
    ..Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11,000 hospitalizations, and 100 deaths every year...